Jansen P A, Gribnau F W, Schulte B P, Poels E F
Br Med J (Clin Res Ed). 1986 Oct 11;293(6552):914-7. doi: 10.1136/bmj.293.6552.914.
One hundred and seventy eight patients admitted to hospital with acute cerebral infarction or transient ischaemic attack were studied to determine if their treatment had been changed during the previous three weeks and to compare their blood pressure after the stroke with premorbid values. Blood pressure measurements taken within one year before the stroke were available for 100 patients; seven of these had had a recent change in antihypertensive or diuretic treatment. Of these, three patients who had started taking frusemide because of hypertension and one whose dosage of a reserpine combination drug had been increased experienced an appreciable decrease in blood pressure immediately after the stroke; they also showed signs of haemoconcentration. The change in treatment probably contributed to the stroke in these four patients. The other three showed a smaller decrease or even an increase in blood pressure and no signs of haemoconcentration; the relation between the change in treatment and stroke is less likely in these patients. The use of high ceiling diuretics such as frusemide in the treatment of hypertension may induce hypovolaemia and hypotension, resulting in cerebral ischaemia, and are therefore best avoided in such treatment.
对178例因急性脑梗死或短暂性脑缺血发作入院的患者进行了研究,以确定他们在过去三周内的治疗是否发生了变化,并比较他们中风后的血压与病前值。100例患者有中风前一年内的血压测量数据;其中7例近期有抗高血压药或利尿剂治疗的变化。其中,3例因高血压开始服用速尿的患者和1例利血平复方药物剂量增加的患者在中风后血压立即明显下降;他们还表现出血液浓缩的迹象。治疗变化可能导致了这4例患者的中风。另外3例患者血压下降较小甚至升高,且无血液浓缩迹象;这些患者中治疗变化与中风之间的关系可能性较小。在高血压治疗中使用速尿等高效能利尿剂可能会导致血容量减少和低血压,从而引起脑缺血,因此在这种治疗中最好避免使用。